Abiopharma

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

Gain Therapeutics to Participate in Upcoming Investor Conferences

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

ADA 2025: Novo Nordisk highlights strong portfolio data with new semaglutide and CagriSema results, redefining possibilities in obesity and diabetes care

Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S

X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA

Windtree Announces Transformational Agreement to Acquire Revenue Generating Environmental Services Business

Arcutis Enrolls First Child in INTEGUMENT-INFANT EvaluatingZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis

NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS

TruBridge, Inc.: TruBridge Announces Participation in the Truist Securities Healthcare Disruptors & Digital Health Conference